The secondary outcomes will be all postoperative complications; major complications (Clavien–Dindo grade > 3); clinically relevant POPF (CR-POPF); delayed gastric emptying (DGE); the length of hospital stay (LOS); time to functional recovery after surgery; serum levels of albumin, pre-albumin, and transferrin; the cost; side effects; and time to the introduction of adjuvant chemotherapy from surgery in patients with pancreatic cancer [14]. The gene discussed is ALB; the disease is familial pancreatic carcinoma.